XML 49 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Taxes  
Schedule of reconciliation of the income tax benefit at the federal statutory tax rate to effective income tax rate

As of

 

December 31, 

 

    

2023

    

2022

  

2021

  

Statutory tax rate

 

21.00

%  

21.00

%

21.00

%

State tax, net of federal benefit

 

10.24

9.83

7.45

Research and development credit

 

0.65

0.78

2.94

Orphan drug credit

 

3.37

2.15

7.58

Stock compensation

 

(1.37)

(0.29)

(1.05)

Other

 

(0.48)

(0.04)

(0.47)

Rate changes

(6.52)

Change in valuation allowance

 

(27.10)

(33.44)

(37.45)

Effective tax rate

 

(0.21)

%  

%

%

Schedule of principal components of deferred tax assets

As of

December 31, 

    

2023

    

2022

Deferred tax assets:

 

  

 

  

Net operating loss carryforwards

$

153,685

$

135,470

Research and development credits

 

16,139

 

14,380

Orphan drug credit

 

25,484

 

19,281

Capitalized license fee

 

2,311

 

2,776

Stock-based compensation

13,159

11,074

Section 174 Costs

50,688

29,663

Deferred revenue

350

438

Accrued Expenses & Other

 

5,680

 

4,536

Total deferred tax assets

 

267,496

 

217,618

Valuation allowance

(267,158)

(217,257)

Net deferred tax assets

338

361

Deferred tax liabilities:

Operating lease right-of-use asset and other

(338)

(361)

Total deferred tax liabilities

$

(338)

$

(361)